Craig Dahl

Craig Dahl started their work experience in 1996 at Dahl Financial Services, where they worked as a Controller. Craig then held various Controller roles at different companies, including FLG Partners, LLC, Profit Velocity Solutions, and Tunitas Therapeutics. In 2013, they worked as a Consultant at Evolv, Inc. and LiveRamp, assisting with audits and month-end close processes. In 2015, they worked as a Consulting Controller at Visionnaire Ventures and as a Controller at Spruce Biosciences. From 2017 to 2019, they were a Controller at Oyster Point Pharmaceuticals, helping the company prepare for a successful IPO. Lastly, they served as a Board Member at Softech from 2008 to 2015.

Craig Dahl earned their MBA in Finance from the Santa Clara University Leavey School of Business, where they attended from 1977 to 1979. Prior to that, they completed their BA in Biological Science at the University of California, Davis, from 1975 to 1977. In addition to their degrees, they hold a certification as a Certified Public Accountant (CPA) from the state of California, although the specific month and year of obtaining this certification are not mentioned.